Loading
Loading
Axsome Therapeutics ceo salary
Herriot Tabuteau, M.D. of Axsome Therapeutics, Inc. (AXSM), received $10,283,492 ($10.3M) in total compensation for FY2025, down 0.8% from the prior year. Stock awards of $5,533,554 were the largest component. Figures come from Axsome Therapeutics, Inc.'s DEF 14A filed 24 Apr 2026 (accession 0001193125-26-177610).
Reported total from the latest DEF 14A pay table. Source filing (accession 0001193125-26-177610). These figures come from Axsome Therapeutics, Inc.'s DEF 14A filed 24 Apr 2026 (accession 0001193125-26-177610).
| Component | Amount |
|---|---|
| Salary | $835,000 |
| Stock awards | $5,533,554 |
| Option awards | $2,833,237 |
| Cash incentive | $876,750 |
| Other | $204,951 |
| Total | $10,283,492 |
FAQ
See also: AXSM ticker page